| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/29/2013 | US8361780 Biological system and assay for identifying modulators of tubulin ligases |
| 01/29/2013 | US8361774 Recombinant type II restriction endonuclease, NmeAIII, and a process for producing the same |
| 01/29/2013 | US8361767 BGL7 beta-glucosidase and nucleic acids encoding the same |
| 01/29/2013 | US8361753 Phosphotriester-modified oligonucleotide primers for nucleic acid amplification |
| 01/29/2013 | US8361742 Method for detecting Candida on skin |
| 01/29/2013 | US8361741 Serum-free growth medium for Acholeplasma laidlawii and methods for retention testing sterilizing grade filters |
| 01/29/2013 | US8361740 Peptide standards |
| 01/29/2013 | US8361739 Luciferase-based assays |
| 01/29/2013 | US8361729 Detection of cells expressing T1R2 taste receptor |
| 01/29/2013 | US8361728 Method for diagnosis of glutamate dehydrogenase disorders |
| 01/29/2013 | US8361727 3′OH-unblocked, nucleotides and nucleosides base modified with labels and photocleavable, terminating groups and methods for their use in DNA sequencing |
| 01/29/2013 | US8361726 Method of detecting tumor-associated DNA in plasma or serum with a premalignant solid tumor |
| 01/29/2013 | US8361725 Detection and typing of bacterial strains |
| 01/29/2013 | US8361724 Methods for evaluating the methylation status of a polynucleotide |
| 01/29/2013 | US8361723 Keratin 8 mutations are risk factors for developing liver disease of multiple etiologies |
| 01/29/2013 | US8361722 Method for diagnosing acute lymphomic leukemia (ALL) using miR-221 |
| 01/29/2013 | US8361721 Methods for detecting, diagnosing and treating human renal cell carcinoma |
| 01/29/2013 | US8361720 Real time cleavage assay |
| 01/29/2013 | US8361719 Methods for quantitative determination of methylation density in a DNA locus |
| 01/29/2013 | US8361718 Methods for nucleic acid manipulation |
| 01/29/2013 | US8361717 Magnetic particles for nucleic acid sequencing and method of sequencing nucleic acid using the same |
| 01/29/2013 | US8361716 Focusing chamber |
| 01/29/2013 | US8361715 Method for suppressing a FRET signal, FRET signal suppressor agents and use in a method for multiplexing biological events |
| 01/29/2013 | US8361714 Micrornas differentially expressed in cervical cancer and uses thereof |
| 01/29/2013 | US8361713 System and apparatus for sequential processing of analytes |
| 01/29/2013 | US8361712 Contamination-free reagents for nucleic acid amplification |
| 01/29/2013 | US8361711 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances |
| 01/29/2013 | US8361710 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21 |
| 01/29/2013 | US8361709 Method of producing tooth, set of teeth, and method of producing tissue |
| 01/29/2013 | US8361708 Human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
| 01/29/2013 | US8361707 Methods for detecting a Mycobacterium tuberculosis infection |
| 01/29/2013 | US8361706 Monoclonal antibodies and uses thereof |
| 01/29/2013 | US8361705 Characterization of N-glycans using exoglycosidases |
| 01/29/2013 | US8361662 Electrocatalyst and enzymatic electrode |
| 01/29/2013 | US8361508 Endothelial cell surface receptors |
| 01/29/2013 | US8361466 Tweak receptor |
| 01/29/2013 | US8361457 Duplexed parvovirus vectors |
| 01/29/2013 | CA2729739C Composite arrays utilizing microspheres |
| 01/29/2013 | CA2677781C Nitrilases |
| 01/29/2013 | CA2528832C Glucose measuring module and insulin pump combination |
| 01/29/2013 | CA2501756C Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage |
| 01/29/2013 | CA2498315C Cytokine production-inducing antibody |
| 01/29/2013 | CA2489360C Methods and compositions for determining methylation profiles |
| 01/29/2013 | CA2488769C Composition and methods for obtaining nucleic acids from sputum |
| 01/29/2013 | CA2483189C Device for closure of a vascular defect |
| 01/29/2013 | CA2462113C Multi-chain eukaryotic display vectors and uses thereof |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2413353C Intervertebral disc |
| 01/29/2013 | CA2325574C Porcine adenovirus type 3 genome |
| 01/29/2013 | CA2258485C Ribonuclease resistant rna preparation and utilization |
| 01/24/2013 | WO2013013206A1 Cardiomyocytes from induced pluripotent stem cells from patients and methods of use |
| 01/24/2013 | WO2013013068A2 Embodiments of a probe and method for targeting nucleic acids |
| 01/24/2013 | WO2013013066A2 Methods for assessing genomic instabilities in tumors |
| 01/24/2013 | WO2013013043A1 Compositions and methods for diagnosing hypercoagulability and hypocoagulability |
| 01/24/2013 | WO2013012947A1 Methods of predicting host responsiveness to cancer immunotherapies by ex vivo induction of leukocyte-function-associated mrnas |
| 01/24/2013 | WO2013012927A2 Oligodendroglioma driver genes |
| 01/24/2013 | WO2013012886A1 Carbocyanines for g-quadruplex dna stabilization and telomerase inhibition |
| 01/24/2013 | WO2013012781A2 Genome-wide methylation analysis and use to identify genes specific to breast cancer hormone receptor status and risk of recurrence |
| 01/24/2013 | WO2013012775A1 Corn event mzdt09y |
| 01/24/2013 | WO2013012749A2 Human zona pellucida glycoproteins, their oligosaccharides, and uses thereof |
| 01/24/2013 | WO2013012708A1 Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays |
| 01/24/2013 | WO2013012674A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | WO2013012440A2 Methods and devices for dna sequencing and molecular diagnostics |
| 01/24/2013 | WO2013012434A1 Bioluminescent stem-loop probes, compositions containing the same and methods utilizing the same |
| 01/24/2013 | WO2013012396A1 A method and apparatus for analyzing interactions of molecules |
| 01/24/2013 | WO2013012332A1 Identification of subjects at risk of developing irritable bowel syndrome |
| 01/24/2013 | WO2013012308A1 Ssr markers for plants and uses thereof |
| 01/24/2013 | WO2013011962A1 Cell culture device, device for long-term monitoring of cell culture, method for long-term cell culture, and method for long-term monitoring of cell culture |
| 01/24/2013 | WO2013011734A1 Method and kit for dna typing of hla gene |
| 01/24/2013 | WO2013011611A1 Nucleic acid analysis method and analysis apparatus |
| 01/24/2013 | WO2013011513A1 Methods of determinig enzyme activity in preserved cell samples |
| 01/24/2013 | WO2013011479A2 Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expression |
| 01/24/2013 | WO2013011378A1 Diagnostic microrna profiling in cutaneous t-cell lymphoma (ctcl) |
| 01/24/2013 | WO2013011178A1 Rapid and accurate analysis of protein sialylation |
| 01/24/2013 | WO2013011153A2 Method for the prognosis and treatment of metastasis in breast cancer |
| 01/24/2013 | WO2013011131A2 Pluripotent tendon and ligament perivascular cells |
| 01/24/2013 | WO2013011113A1 Methods for determining treatment response in patients infected with hcv genotype 4 |
| 01/24/2013 | WO2013011072A1 Carbapenemase and antibacterial treatment |
| 01/24/2013 | WO2013011055A1 Means and methods for determining clostridial neurotoxins |
| 01/24/2013 | WO2013011044A1 Chac1 transcript variants as marker for breast cancer |
| 01/24/2013 | WO2013010999A1 Method and system for analyzing a liquid cell sample by digital holographic microscopy |
| 01/24/2013 | WO2013010906A2 Methods and reagents for efficient control of hiv progression |
| 01/24/2013 | WO2013010574A1 Method and device for detection and quantification of thermoduric microorganisms in a product |
| 01/24/2013 | WO2013010511A1 Determination of gene expression level of one cell type |
| 01/24/2013 | WO2013010333A1 Method of reverse transcription-polymerase chain reaction |
| 01/24/2013 | WO2013010260A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | WO2013010225A1 Enzymes for degrading organophosphates |
| 01/24/2013 | WO2012152747A3 Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis |
| 01/24/2013 | WO2012145399A3 Methods of diagnosing cancer in a patient |
| 01/24/2013 | WO2012142213A3 Safe sequencing system |
| 01/24/2013 | WO2012138955A3 CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS |
| 01/24/2013 | WO2012135658A3 Sequence preserved dna conversion for optical nanopore sequencing |
| 01/24/2013 | WO2012135091A3 Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and esophageal adenocarcinoma (eac) |
| 01/24/2013 | WO2012129363A3 Single cell nucleic acid detection and analysis |
| 01/24/2013 | WO2012128577A3 Method for performance analysis and screening of septicaemia protein therapeutic agents |
| 01/24/2013 | WO2012109586A3 Methods and systems for evaluating and predicting the reactivity of monooxygenase enzymes |
| 01/24/2013 | WO2012103031A3 Detection of genetic abnormalities |
| 01/24/2013 | WO2012093821A3 Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same |
| 01/24/2013 | WO2012087769A3 A novel cell-based assay to identify polymerase inhibitors for viral infectious disease |
| 01/24/2013 | WO2012078885A3 Systems and methods for feedstock quality assessment |